TLR8 combined withTLR3 or TLR4 agonists enhances DC-NK driven effector Tc1 cells
- 2 November 2017
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 193, 58-66
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (1R03AI103750-01A1)
- National Institutes of Health (1R03AI103750-01A1)
This publication has 47 references indexed in Scilit:
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and ImmunityImmunity, 2011
- TLR-based immune adjuvantsVaccine, 2011
- Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cellsHuman Immunology, 2010
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Inflammatory cytokines as a third signal for T cell activationCurrent Opinion in Immunology, 2010
- Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunityJournal of Inflammation, 2010
- Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activationBlood, 2008
- Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cellsHuman Immunology, 2007
- Cooperation of Toll-like receptor signals in innate immune defenceNature Reviews Immunology, 2007
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004